Company Filing History:
Years Active: 1999-2014
Title: The Innovative Contributions of Rochelle Witt
Introduction
Rochelle Witt is a prominent inventor based in San Francisco, CA, known for her significant contributions to the field of biotechnology. With a total of 8 patents to her name, she has made remarkable advancements in the production of recombinant lentivirus vectors. Her work has implications for various applications in gene therapy and medical research.
Latest Patents
Among her latest patents is a method and means for producing high titer, safe recombinant lentivirus vectors. This innovation involves lentiviral vectors modified at the 5' LTR or both the 5' and 3' LTRs, which are essential for the production of recombinant lentivirus vectors. These vectors can be produced without a functional tat gene, and multiple transformations of the host cell with the vector carrying the transgene significantly enhance virus production. Additionally, the vectors can contain inducible or conditional promoters, further expanding their utility in research and therapeutic applications.
Career Highlights
Rochelle has worked with notable companies in the biotechnology sector, including Cell Genesys, Inc. and Gbp IP, LLC. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.
Collaborations
Throughout her career, Rochelle has collaborated with esteemed colleagues such as Luigi Naldini and Thomas L. Dull. These partnerships have fostered an environment of innovation and have led to significant advancements in their shared research interests.
Conclusion
Rochelle Witt's contributions to the field of biotechnology through her patents and collaborations highlight her role as a leading inventor. Her work continues to influence the development of safe and effective gene therapy solutions.